Mayo Clinic
This study is being done to study the combination of pyridostigmine and low-dose Droxidopa for the treatment of orthostatic hypotension.
Inclusion Criteria 1. The presence of OH (fall in systolic BP \>=30 mm Hg) is required for this study. 2. Autonomic testing and clinical evaluation demonstrates OH to be of neurogenic etiology. Exclusion Criteria: 1. Pregnant or lactating females. 2. Chronic illnesses or the presence of other conditions that potentially involve the CNS or affect autonomic testing. These include congestive heart failure, recent (\<6 months) myocardial infarct, severe anemia, diabetes mellitus, alcoholism, malignant neoplasms, amyloidosis, hypothyroidism, sympathectomy, cerebrovascular accidents, and neurotox…
100 mg tablets by mouth three times a day
60 mg tablets by mouth three times a day
Looks exactly like the study drug but contains no active ingredients
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.